Hayashi, Norio <br/><br/>
Simeprevir with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial.  [electronic resource] 

 -  Journal of hepatology  Aug 2014 
 - 219-27 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0641 
<br/><br/><label>Standard No.: </label>10.1016/j.jhep.2014.04.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepatitis C--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Heterocyclic Compounds, 3-Ring--administration & dosage<br/>Humans<br/>Interferon-alpha--administration & dosage<br/>Interferons<br/>Interleukins--genetics<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>RNA, Viral--analysis<br/>Recombinant Proteins--administration & dosage<br/>Ribavirin--administration & dosage<br/>Simeprevir<br/>Sulfonamides--administration & dosage<br/>Treatment Failure